David Graham Tew

Title: David Graham Tew: Innovator in Oligonucleotide Production

Introduction

David Graham Tew is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of oligonucleotide production, holding 2 patents that focus on novel processes for creating chemically modified oligonucleotides. His work is particularly relevant for therapeutic applications.

Latest Patents

Tew's latest patents include innovative processes for the production of oligonucleotides. These processes are designed to enhance the production of chemically modified oligonucleotides, which are essential for various therapeutic uses. The patents disclose methods that improve the efficiency and effectiveness of oligonucleotide synthesis.

Career Highlights

David Graham Tew is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in the development of oligonucleotide technologies. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the realm of genetic therapies.

Collaborations

Throughout his career, Tew has collaborated with esteemed colleagues such as Andreas Crameri and Malcolm Leithhead Hill. These partnerships have furthered the advancement of oligonucleotide research and development.

Conclusion

David Graham Tew's contributions to oligonucleotide production highlight his innovative spirit and dedication to advancing therapeutic technologies. His patents and collaborations reflect a commitment to improving healthcare through scientific innovation.